Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

622 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Five-year outcomes of moderately hypofractionated proton therapy incorporating elective pelvic nodal irradiation for high-risk prostate cancer.
Choo R, Corbin K, Merrell K, Stish B, Pisansky TM, Davis BJ, Amundson A, Hillman DW, Mitchell C, Wong W, Vargas C, Rwigema JC, Keole S, Vora S, Daniels T. Choo R, et al. Among authors: daniels t. Int J Radiat Oncol Biol Phys. 2024 Dec 11:S0360-3016(24)03722-2. doi: 10.1016/j.ijrobp.2024.11.115. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39672515
A Prospective Trial of Intensity Modulated Radiation Therapy (IMRT) Incorporating a Simultaneous Integrated Boost for Prostate Cancer: Long-term Outcomes Compared With Standard Image Guided IMRT.
Schild MH, Schild SE, Wong WW, Vora SA, Keole SR, Vargas CE, Daniels TB, Ezzell GA, Nguyen BD, Roarke MC. Schild MH, et al. Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):1021-1025. doi: 10.1016/j.ijrobp.2017.01.219. Epub 2017 Feb 1. Int J Radiat Oncol Biol Phys. 2017. PMID: 28332984 Clinical Trial.
Late Toxicity of Moderately Hypofractionated Intensity-Modulated Proton Therapy Treating the Prostate and Pelvic Lymph Nodes for High-Risk Prostate Cancer.
Choo R, Hillman DW, Mitchell C, Daniels T, Vargas C, Rwigema JC, Corbin K, Keole S, Vora S, Merrell K, Stish B, Pisansky T, Davis BJ, Amundson A, Wong W. Choo R, et al. Among authors: daniels t. Int J Radiat Oncol Biol Phys. 2023 Apr 1;115(5):1085-1094. doi: 10.1016/j.ijrobp.2022.11.027. Epub 2022 Nov 22. Int J Radiat Oncol Biol Phys. 2023. PMID: 36427645
Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy.
Laughlin BS, Voss MM, Toesca DAS, Daniels T, Golafshar MA, Keole SR, Wong WW, Rwigema JC, Davis B, Schild SE, Stish BJ, Choo R, Lester S, DeWees TA, Vargas CE. Laughlin BS, et al. Among authors: daniels t. Adv Radiat Oncol. 2022 Dec 10;8(2):101143. doi: 10.1016/j.adro.2022.101143. eCollection 2023 Mar-Apr. Adv Radiat Oncol. 2022. PMID: 36845611 Free PMC article.
Proton therapy for sarcomas.
Keole S, Ashman JB, Daniels TB. Keole S, et al. Cancer J. 2014 Nov-Dec;20(6):409-14. doi: 10.1097/PPO.0000000000000084. Cancer J. 2014. PMID: 25415687 Review.
622 results